FIELD: chemistry.
SUBSTANCE: invention relates to a new dimethyl 7-methyl-2-(n-tolyl)-4-phenylpyrrolo[2,1-ƒ][1,2,4]triazine-5,6-dicarboxylate 
.
EFFECT: new compound with anticoagulant activity was obtained, which can be used to prevent thrombotic conditions in severe forms of viral infection.
1 cl, 5 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PRODUCT WITH ANTICOAGULANT (INHIBITOR OF FACTOR IIA), ANTITHROMBOTIC, ANTI-INFLAMMATORY ACTIVITIES AND CONTAINING 5,7-DI(THIOPHEN-2-IL)-4,5-DIHYDRO-[1,2,4]TRIAZOLO[1,5-a ]PYRIMIDINE | 2022 |
|
RU2798587C1 |
| DIMETHYL 7-METHYL-2-(PYRROLIDINE-1-yl)-4-PHENYLPYRROLO[2,1-ƒ][1,2,4]TRIAZINE-5,6-DICARBOXYLATE AND DIMETHYL 7-METHYL-2-(4-R-PHENYL)-4-(4-R-PHENYL)PYRROLO[2,1-ƒ][1,2,4]TRIAZINE-5,6-DICARBOXYLATES EXHIBITING ANTIVIRAL ACTIVITY | 2021 |
|
RU2790376C1 |
| DNA-APTAMERS INTERACTING WITH PROTHROMBIN | 2018 |
|
RU2703799C1 |
| METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
| METHOD FOR PREVENTION OF VENOUS THROMBOEMBOLIA IN PATIENTS WITH CERVICAL CANCER | 2016 |
|
RU2641058C1 |
| AMINE DERIVATIVES OF DIARYLPYRIMIDINES AS INHIBITORS OF NITRIC OXIDE AND INTERLEUKIN 6 RELEASE | 2022 |
|
RU2812550C1 |
| 3-BENZYL-5-METHYL-6-(PHENYLTHIO)-[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7(3H)-ONE, WHICH HAS ANTIVIRAL ACTIVITY AGAINST THE SARS-CoV2 CORONAVIRUS | 2022 |
|
RU2808622C1 |
| USE OF SUBSTITUTED 2-(2-(4,4,6-TRIMETHYL-2-OXO-4N-PYRROLO[3,2,1-IJ]QUINOLINE-1(2H)-YLIDENE)HYDRAZINYL)THIAZOLE-4(5H)-ONES AS INHIBITORS OF BLOOD COAGULATION FACTORS XA AND XIA AND METHOD FOR THEIR PREPARATION | 2023 |
|
RU2819271C1 |
| METHOD FOR OPTIMIZING LABORATORY DIAGNOSIS OF THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2789822C1 |
| NEW 2-STYRYL-DERIVATIVE OF 4-(2,6-DIMETHYL-4-OXO-5-PHENYL-4H-PYRIMIDINE-1-YL)-BENZSULFAMIDE HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2017 |
|
RU2652993C1 |
